Fatigue is often one of the most common side effects of breast cancer treatment.
Nancy Stewart, Master’s prepared RN from NYU Langone Perlmutter Cancer Center, delves into how to recognize cancer-related fatigue, possible causes, and how to manage it.
For more information, visit our website at sharecancersupport.org or call our Helpline at 844.ASK.SHARE (844.275.7427).
eeling worn out and exhausted all the time? You may be experiencing cancer-related fatigue. Tune in to this webinar to learn what cancer-related fatigue is, how to spot it, and how to manage it.
In this presentation, we will discuss Chemotherapy Induced Peripheral Neuropathy with strict application of Evidence based medicine about the magnitude of the problem, how to diagnose, how to prevent and how to treat?
Following diagnosis and treatment for breast cancer, many women experience changes in their sexuality. In this webinar, Madeleine M. Castellanos, MD, a psychiatrist specializing in sex therapy and sexual medicine, addresses the physical, psychological, and relationship issues that often emerge and explores strategies to find happiness and fulfillment.
eeling worn out and exhausted all the time? You may be experiencing cancer-related fatigue. Tune in to this webinar to learn what cancer-related fatigue is, how to spot it, and how to manage it.
In this presentation, we will discuss Chemotherapy Induced Peripheral Neuropathy with strict application of Evidence based medicine about the magnitude of the problem, how to diagnose, how to prevent and how to treat?
Following diagnosis and treatment for breast cancer, many women experience changes in their sexuality. In this webinar, Madeleine M. Castellanos, MD, a psychiatrist specializing in sex therapy and sexual medicine, addresses the physical, psychological, and relationship issues that often emerge and explores strategies to find happiness and fulfillment.
It is an oncologic emergency. This slides contains a brief discussion on mechanism of spinal cord compression , common malignancies presenting with spinal cord compression , approach to a patient with cord compression like features and management this catastrophic situation.
Radiotherapy in hepatocellular carcinomasPratap Tiwari
External Radiotherapy in hepatocellular carcinomas (HCC). A brief summary of the guidelines statements on radiotherapy role in hepatocellular carcinoma (hcc).
It is an oncologic emergency. This slides contains a brief discussion on mechanism of spinal cord compression , common malignancies presenting with spinal cord compression , approach to a patient with cord compression like features and management this catastrophic situation.
Radiotherapy in hepatocellular carcinomasPratap Tiwari
External Radiotherapy in hepatocellular carcinomas (HCC). A brief summary of the guidelines statements on radiotherapy role in hepatocellular carcinoma (hcc).
Dr. Colin Depp, Associate Professor of Psychiatry at the University of California, San Diego and CREST.BD member, describes research on the changes, including positive ones, that occur as people grow older with bipolar disorder. He shares evidence and considerations for treatments for bipolar disorder in older adults, as well as an overview of the lifestyle and behavioral determinants of healthy aging. He also presents new research on the importance of these factors in aging well with bipolar disorder.
Colin Depp, Ph.D. is an Associate Professor of Psychiatry at the University of California, San Diego. He is also Associate Director of Research Education and Training Division of the San Diego Clinical Translational Science Institute and psychologist at the Veterans Administration Healthcare System in San Diego. His research focuses on psychosocial interventions for bipolar disorder, use of technology for behavioral change, and the determinants of successful aging in people with mental illnesses. Dr. Depp is a principal investigator or co-investigator on multiple studies and he on the Editorial Board of Bipolar Disorders.
This slideshare is a summary of a study on patient beliefs about low back pain in an outpatient physical therapy clinic in Trinidad. The study is a retrospective analysis of survey data using the Back-PAQ measure. Results show a high proportion of negative beliefs particularly around protection of the back. The study highlights the need to address these unhelpful beliefs with appropriate interventions that decrease fear and protection of the back.
OBJECTIVES
--Describe and Discuss what is Pain Recovery
--Demonstrate the difference between Acute and Chronic Pain using case examples
--Explain the symbiotic relationship between Chronic Pain-Substance Abuse and Mental Health Disorders
--Identify and Recommend Multidisciplinary Treatment Options for the Behavioral HealthCare Field
impact of riyazat ( physical activity) on mental health During pregnancy.pptxFaizaFurqan1
impact of physical exrecise on mental health during pregnancy
as we all know that during pregnancy women undergoes many changes like weight gain , nousea, vomitting , chages in the body shape mood swings so to counter all these physical exerscise like mild waliking jogging ,swimming are important and also a low self esteem , depression and anxiety of the outcome of the pregnancy , fear of vaginal deliveries
Reviewing Cognitive Treatment for Eating Disorders: From Standard CBT Efficac...State of Mind
Reviewing Cognitive Treatment for Eating Disorders: From Standard CBT Efficacy to Worry, Rumination and Control Focused Interventions - EACBT 2015 Jerusalem
Similar to Cancer-Related Fatigue: How to Address and Manage It (20)
Let's Talk About It: Breast Cancer (Survivor’s Guilt)bkling
The question of “Why me?” often exemplifies the experience of survivor’s guilt. Feeling survivor’s guilt is more common than you may think and can be triggered in different ways. Your positive news at a follow-up visit, regaining strength when treatment ends and manageable side effects are all events that may counter-intuitively lead to stress or even shame. Feeling the sting of hurt when others share good news and you feel the anguish of your losses, by comparison, can be hard to acknowledge and know how to manage. The loss of a fellow survivor naturally gives rise to grief which can be compounded by guilt. Let’s Talk About It.
MBC Support Group for Black Women – Insights in Genetic Testing.pdfbkling
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)bkling
Your mindset is the way you make sense of the world around you. This lens influences the way you think, the way you feel, and how you might behave in certain situations. Let's talk about mindset myths that can get us into trouble and ways to cultivate a mindset to support your cancer survivorship in authentic ways. Let’s Talk About It!
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...bkling
Making treatment decisions is stressful. The work of understanding complex medical information, crafting questions for your medical team, and trusting oneself is hard. We break down this intense time in ways that might feel more manageable and help you regain a sense of calm as you work hard to care for yourself at each turn in the road. Let’s talk about it.
Report Back from SGO: What’s the Latest in Ovarian Cancer?bkling
Are you curious about what’s new in ovarian cancer research or unsure what the findings mean? Join Dr. Elena Pereira, a gynecologic oncologist at Lenox Hill Hospital, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Pereira will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Part I - Anticipatory Grief: Experiencing grief before the loss has happenedbkling
Anticipatory grief is the emotional experience when there is an impending loss that will occur. Often, people associate loss and grief with death, this is just one area in which grief and loss can occur. Anticipatory grief is often a slower grieving process marked by intermittent, small or large losses. In the world of cancer, anticipatory grief may show up in a variety of ways, such as before a major surgery, losing hair from chemotherapy treatment or caring for a loved one with advanced cancer.
Learn about anticipatory grief and ways to cope with it. We will also explore methods to heal from this challenging experience.
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...bkling
A cancer diagnosis is stressful. Feelings of worry, fear, self-doubt, sadness, and loneliness are normal but can feel exhausting and consuming at times. Cultivating a habit of thought-watching and learning to recognize thought traps that might be contributing to our discomfort can help us respond and care for ourselves in helpful ways. Learn more about the connection between what we think and how we feel and what you can do about it that might impact how you feel today. Let’s talk about it.
Advocating for Better Outcomes: Ovarian Cancer and Youbkling
Many parts of your life can affect your health and your cancer risk. Things like your race, ethnicity, where you live, and your finances matter. Even so, how can you get the health care you need and lower your cancer risk? What should you and your family do if you need to speak up?
Join this special talk about knowing your risk, ovarian cancer care, and ways we can speak up to improve our health. provided by two experts from Memorial Sloan Kettering Cancer Center (MSK) and SHARE.
Do you want to feel empowered and confident in preserving your independence and lowering your risk for injury? Learn how to reduce the risk of injury, how to fall safely, and maximize quality of life. Avoid common pitfalls and connect with others who share this concern!
Speakers: Ayden Jones, Falls Prevention Consultant and A Matter of Balance Master Trainer, and Janvier Hoist-Forrester, OTS.
Embracing Life's Balancing Act: Part 2 - Fall Action Planbkling
Do you want to feel empowered and confident in preserving your independence and lowering your risk for injury? Learn how to reduce the risk of injury, how to fall safely, and maximize quality of life. Avoid common pitfalls and connect with others who share this concern!
Speakers: Ayden Jones, Falls Prevention Consultant and A Matter of Balance Master Trainer, and Janvier Hoist-Forrester, OTS.
Let's Talk About It: Communication, Intimacy, and Sex… Oh My!bkling
Changes to your body are normal to experience related to a cancer diagnosis. But the grief and the learning to live with a changed body take time. But what if you share your body with someone else? What if finding pleasure and connection through intimacy feels like an overwhelming or insurmountable obstacle on your road to healing? Let's talk together about our personal experiences and questions surrounding this important topic of communication and intimacy.
Let's Talk About It: To Disclose or Not to Disclose?bkling
Sharing your cancer diagnosis with others can bring up a range of unexpected feelings and questions. Deciding who you tell, how much to share, and why are all important things to consider. The answer to these questions is personal and it varies not only between survivors but also in different settings and relationships in your life. We talk together about personal experiences and questions surrounding this important topic.
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
Dr. Ebony Hoskins, gynecologic oncologist at MedStar Washington Hospital Center, provides a comprehensive update from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer. Dr. Hoskins breaks down the research presented at the conference, discusses new developments, and addresses the most pressing questions.
Learn Tips for Managing Chemobrain or Mental Fogginessbkling
Chemobrain, or mental fogginess, is experienced by many patients during and after cancer treatment. But what are some strategies that help?Dennis Lin, OTD, OTR/L, Occupational Therapist at City of Hope National Medical Center, will provide tips on how you can manage chemobrain and support better engagement in your daily life.
Vaccines: Will they become a form of Secondary and Primary Breast Cancer Prev...bkling
Our guest speaker Lee Gravatt Wilke, MD, Senior Medical Director at the University of Wisconsin School of Medicine and Public Health, explains the current state of vaccine clinical trials in breast cancer followed by a review of the STEMVAC trial, design of the vaccine, and the current state of the accrual and next steps.
Let's Talk About It: Uterine Cancer (Advance Care Planning)bkling
Although it can be a difficult topic, advance care planning is very important for anyone facing a cancer diagnosis. The goal of advance care planning is to set up a plan to make sure you get the care you want in the future. It is critical to prepare for future decisions about your medical care with your family and support system. We discuss how to start and continue those important conversations. Learn about the differences between palliative care and hospice, when to bring up your wishes with your medical team, and how to prepare your family for navigating these decisions.
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...bkling
You’ve been treated for uterine cancer. Now what? With surveillance strategies varying from doctor to doctor, it can be hard to know which advice you should follow. Dr. Jennifer Mueller, Head of the Endometrial Cancer Section, Gynecologic Oncology Service at Memorial Sloan Kettering Cancer Center, delves into surveillance guidelines, which tests to consider, and how to keep an eye out for any symptoms which could indicate recurrence.
Understanding and Managing Chemo-Induced Peripheral Neuropathy (CIPN)bkling
Certain chemotherapy drugs can cause chemotherapy-induced peripheral neuropathy (CIPN), which is one of the most common side effects of treatment. Chemotherapy treatments cause peripheral neuropathy by damaging the nerves in the fingers, hands, arms, legs, and feet. This can lead to symptoms including pain, numbness, tingling, and difficulty with mobility, which can greatly impact one’s quality of life. Dr. Anasheh Halabi is an Assistant Clinical Professor in Neuromuscular Medicine at UCLA who specializes in neuropathies and is a leading specialist in caring for patients with neurotoxicities related to cancer drugs. She discusses chemotherapy-related neuropathies, expectations, and management. The perspective of a patient who has experienced CIPN will also be included in the program.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
2. Cancer-Related Fatigue (CRF)
o Defined as “a distressing, persistent, subjective sense of physical,
emotional and/or cognitive tiredness or exhaustion related to cancer or
cancer treatment that is not proportional to recent activity and interferes
with usual functioning.”
o Differs from non-disease related fatigue
o More severe, disabling, and challenging to relieve
o Not only not relieved by rest but may, in fact, be worsened with rest
o Up to one-third of survivors have significant fatigue 6 years after
treatment
Berger et al., 2012; Bower et al., 2018; Coughlin et al., 2015
3. CRF Criteria
1) A period of 2 weeks or longer within the preceding month during which
significant CRF or diminished energy was experienced each day or almost every
day along with additional CRF-related symptoms
2) The experience of CRF results in significant distress or impairment of function
3) The presence of clinical evidence suggesting that CRF is a consequence of
cancer or cancer therapy
4) CRF is not primarily a consequence of a concurrent psychiatric condition, such
as major depression
Berger at al., 2012
4. CRF is multidimensional
o Physical fatigue
o Affective (emotional) fatigue
o Cognitive fatigue
o Interventions may be effective for one component of CRF and not the
others
Schmidt et al., 2017; Sorensen et al., 2020
5. CRF in breast cancer survivors (BCS)
o One of the most frequent and distressing symptoms
o As many as 95% of BCS experience cancer-related fatigue at some point
in their disease trajectory
o Symptom onset may occur during or remote from treatment
o Lingering effect - does not resolve with tumor control or treatment
cessation
o Impacts quality of life, interpersonal relationships, and work productivity
Berger at al., 2012; Inglis et al., 2020; Person et al., 2020
6. What Causes CRF?
o Multifactorial biochemical, physiological, psychological, psychosocial, and
behavioral factors:
• Tumor characteristics and stage
• Direct effects of cancer
• Dysfunctional secretion of endocrine and inflammatory molecules
• Comorbidities
• Psychosocial issues
• Side effects of treatment
Huang et al., 2019; Inglis et al., 2020; Person et al., 2020; Puigpinos-Riera et al., 2020; Schmidt et al., 2017
7. Variability in CRF among BCS
• Low or very low symptoms throughout and following treatment –
comparable to women of similar age with no cancer history
• High fatigue during treatment, followed by recovery
• Late onset fatigue
• Persistently elevated fatigue
o Psychosocial factors were strongest predictors of group membership
o Treatment types impact fatigue trajectories
Bower et al., 2018
8. Factors Affecting Physical Health/Quality of Life in BCS
o Depression
o Anxiety
o Sleep disturbance
o Medical comorbidities
o Low socioeconomic status
o Lack of health insurance
Coughlin et al., 2015; Fox et al., 2020; Huang et al., 2019
9. Risk Factors for CRF
o Elevated BMI
o Poor sleep quality
o Depression/anxiety
o Childhood adversity
o Low socioeconomic status
o Comorbidities
Berger at al., 2012; Bowers at al., 2018; Person et al., 2020; Puigpinos-Riera et
al., 2019; Williams et al., 2021
o Spiritual suffering
o Living alone
o <50 years of age
o Physical inactivity
o Pre-existing fatigue
10. Treatable Contributing Factors
o Side effects of medication
o Pain
o Anemia
o Comorbidities – hypertension, hypothyroid
o Nutritional imbalances
o Mental health issues/emotional distress
o Requires medical evaluation and cooperation between oncologists, PCPs,
and mental health providers
Berger et al., 2012; Schmidt et al., 2017
11. Symptom Clusters
o Two or more concurrent symptoms that are related to one another
o Hasten or potentiate the effects of the other(s)
o Sleep problems, depression, CRF, and poorer overall quality of life
o Hot flashes, pain, CRF
o Fatigue, anxiety, and decreased quality of life
o Pain, fatigue, and psychological distress - associated with premenopausal
status, working less than full-time, lymphedema, and disability
Berger et al., 2012; Bjerkeset et al., 2020; Fox et al., 2020; Williams et al., 2021
12. Depression, Anxiety, and CRF
o Highly associated with affective fatigue
o History of depression and depressive symptoms predict post-treatment
fatigue
o Use of psycho-pharmaceuticals associated with CRF
o Pattern of adjustment to stressful life events is predictive for CRF
o Anxiety and CRF are associated with poor treatment adherence
o Resilience is protective against CRF
Bower et al., 2018; Puigpinos-Riera et al., 2020; Schmidt et al., 2017; Williams et al., 2021
13. Sleep Disturbance and CRF
o Multifactorial and interconnected
o Interventions should be targeted to cause of poor sleep quality
o Sleep disturbance due to physical fatigue versus affective fatigue
o Sleep quality measured during chemotherapy showed deficits in those with
both low and high self-reported symptoms
o Subjective sleep quality may differ from objective sleep quality
o Sleep disturbance associated with younger age group
o Less symptom burden in married participants
o Positive correlation with obesity and medical comorbidities
Fox et al., 2020
14. Hot Flashes
o Common for women undergoing endocrine therapy
o Impact both physical and cognitive fatigue
o Associated with sleep disturbance and CRF
o Acupuncture might benefit, but more research is needed
o Supplements may improve symptoms
Berger et al., 2012; Schmidt et al., 2017
15. Social Support and CRF
o Social support improves quality of life in BCS
o Support from spouses, partners, children, siblings, friends, colleagues,
and healthcare workers has been shown to be beneficial to feelings of
social support
o Lack of social support is associated with mental fatigue but not physical
fatigue
o Being single increases CRF
Sorensen et al., 2020
16. Population-Specific Considerations
o Fewer studies focus on the experience of African-American BCS
o African-American BCS have higher rates of obesity and lower rates of
physical activity than white survivors
o Spirituality and faith-based support
o Strong religious beliefs are protective against CRF
Coughlin et al., 2015; Puigpinos-Riera et al., 2020
17. Age and CRF
o Premenopausal women are at increased risk for CRF
• Premature menopause
• Infertility
• Risk of recurrence
• Caregiver responsibilities
• Concerns about employment/career
o Different issues for postmenopausal women
Coughlin et al., 2015; Puigpinos-Riera et al., 2020; Sorensen et al., 2020
18. Obesity and CRF
o Often present at diagnosis – risk factor for breast cancer and cancer
recurrence
o Weight gain is common in post-menopausal women
o May occur as a side effect of breast cancer treatment
o Associated with chronic inflammation
o Higher BMI at baseline is associated with increased physical fatigue
before, during, and after treatment
Coughlin et al., 2015; Inglis et al., 2020; Schmidt et al., 2017
19. CRF and chemotherapy
o CRF is a common symptom in BCS undergoing chemo
o Fatigue peaks about 4 days after chemo, then gradually subsides
o For some BCS, fatigue does not subside prior to the next cycle and
accumulates over time
Hsiang-Pin et al., 2019
20. Benefits of Physical Activity for BCS
o Inverse relationship between physical activity and recurrence and breast
cancer-related death
o Greater physical activity associated with decrease in recurrence and
mortality compared to less activity
o During breast cancer treatment, early intervention can provide long-
lasting benefits that last after treatment is completed
Berger et al., 2012; Coughlin et al., 2015; Kim et al., 2019; Schmidt et al., 2015
21. Exercise and CRF
o The most effective intervention for CRF (moderate benefit)
o Aerobic and resistance exercise, both jointly and separately, have
demonstrated effectiveness
o Performed in a supervised or home-based environment
o Should be individualized, with gradual progression of intensity
o Effects depend on stage of treatment and type of intervention
o Majority of BCS do not meet physical activity guidelines
Berger at el., 2012; Ehlers et al., 2020; Gebruers et al., 2018; Hagstrom et al., 2016; Huang et al., 2019; Kim et al., 2019; Schmidt et al., 2015
23. Benefits of Exercise for BCS
Positive effects on:
• Body image/self-esteem
• Emotional well-being
• Sexuality
• Sleep disturbances
• Social functioning
• Anxiety
• Pain
Coughlin et al., 2015
24. How Does Exercise Help?
o Inactivity leads to deconditioning, muscle wasting, and sleep disturbance
o Increased levels of moderate to strenuous activity may mitigate fatigue
through various metabolic and inflammatory pathways
o Improvements in muscle strength, aerobic capacity, and fatigue
o Beneficial in activities of daily living
Berger et al., 2012; Gebruers et al., 2018; Huang et al., 2019; Juvet et al., 2017
25. Psychosocial Benefits
o Increased self-esteem and health-related quality of life
o Decreased anxiety and depression
o Peer-based exercise programs demonstrate benefits from interacting
with other BCS
o Decreased affective and cognitive fatigue, although to a lesser degree
than physical fatigue
Gebruers et al., 2018; Juvet et al., 2017; Kim et al., 2019; Schmidt et al., 2017
26. Exercise Throughout the Treatment Continuum
o BCS who were physically active prior to diagnosis were more likely to
achieve desired activity levels
o Interventions implemented during adjuvant chemotherapy
demonstrated a small to moderate effect
o Resistance exercise during adjuvant radiotherapy demonstrated
reduction in CRF
o Benefits increase for programs started after treatment is completed
o Wearable sensors and mobile health tools provide an opportunity to
engage in physical activity
Ehlers et al., 2020; Gebruers et al., 2018; Kim et al., 2019; Juvet et al., 2017
27. Barriers to Exercise
o Treatment-related side effects – dizziness, nausea, chemotherapy-
induced neuropathy (tingling in the hands and feet), joint pain, too tired
to exercise
o Class not tailored to BCS – feel like an outsider (body image, hair loss)
o Decreased arm mobility/pain
o Concern about lymphedema
o Prior sedentary lifestyle
Kim et al., 2019
28. Resistance Exercise (RE) and CRF
o Counteracts muscle wasting, improves deficits in affected limb and functional well-
being in BCS
o RE during adjuvant chemotherapy decreased CRF and improved quality of life as
compared to a relaxation control group
o Little demonstrated benefit for affective or cognitive fatigue
o RE improved CRF and quality of life in previously sedentary BCS
o Moderate-intensity RE after treatment showed greater benefits than lower-intensity
RE, or aerobic exercise at any intensity
o Resistance training alone, or in combination with aerobic conditioning, seems to
provide the best results with regard to physical performance outcomes and perceived
fatigue
Gebruers et al., 2018; Hagstrom et al. 2016; Juvet et al., 2017; Schmidt et al., 2015
29. High Intensity Interval Training (HIIT) During
Chemotherapy and CRF
o 16 week program, broken into 3 groups:
• Resistance training & HIIT
• Aerobic exercise & HIIT
• Usual care
o Resistance training & HIIT prevented increases in physical and cognitive
fatigue
o Aerobic exercise & HIIT decreased pain and improved emotional
functioning
Mijwel et al., 2017
30. Aerobic Exercise and CRF
o Improves both physical and affective fatigue
o May impact CRF through:
• Mobilizing body fat
• Increased insulin sensitivity/glucose uptake
• Decreasing inflammatory cytokines
Berger et al., 2012; Mijwel et al., 2017
31. 12-week Home-Based Brisk Walking Program
o Women undergoing adjuvant chemotherapy
o Progressed from 3-5 times/week, 15-40 min/session
o Fatigue levels increased over time for both walkers and control groups
o Walkers demonstrated less fatigue than control group
o Effects lasted 9 months after completion of exercise program
o Women who exercised prior to their diagnosis had less fatigue than
those who exercised less
Huang et al., 2019
32. Lymphedema Concerns
o Outdated recommendations to “not lift anything heavy” with the
affected arm
o Endurance training in affected limb improves quality of life in BCS
o Supervised and progressive resistance exercise is beneficial in regaining
strength and functioning on the affected side
o Resistance training has not been shown to increase incidence of
lymphedema
Puigpinos-Riera et al., 2020; Schmidt et al., 2015
33. Psychosocial and Complementary Interventions
o Cognitive Behavioral Therapy – not readily available, can be costly
o Counseling
o Support groups
o Expressive therapies
o Relaxation/Imagery
o Acupressure/Acupuncture
o Mostly weak evidence, more research needed
Berger et al., 2012; Puigpinos-Riera et al., 2020; Schmidt et al., 2017
34. Yoga and CRF
o 8-week supervised program showed a large effect on physical fatigue in
the post-treatment setting, small effect on women undergoing treatment
o Medium impact on cognitive fatigue
o No impact on emotional fatigue
Dong et al., 2019
35. Swedish Massage Therapy
o One 6-week study showed massage reduces CRF compared to control
groups receiving either a light-touch intervention or on a wait-list
o Prior studies have demonstrated that massage decreases depression,
anxiety, and pain in BCS
o Further studies needed
Kinkead et al., 2018
36. Art Therapy
o Offers a way to express feelings that are difficult to communicate
verbally
o Includes music, visual arts, dance & movement, sculpture, poetry, drama
o May provide benefits for BCS with respect to anxiety, depression, and
fatigue
o Studies have been short-term and in group settings
o More studies needed
Tang et al., 2018
37. Music Therapy and Radiotherapy-Induced
Fatigue
o Individual 30-40 minute sessions with a professional music therapist
o Twice weekly, at three different times during treatment
o Each session progressed through slow tempo songs chosen by therapist,
favorite songs chosen by the participant, faster tempo songs chosen by
the therapist, and concluded with a song performed by an orchestra and
singer
o Improved fatigue, symptoms of depression, and quality of life versus
control group
Alcantara-Silva et al., 2018
38. Diet
o Reduced risk of non-cancer mortality with healthy diet
o In post-menopausal women, lower diet quality is associated with shorter
sleep duration
o In one study, higher soy and cruciferous vegetables (broccoli,
cauliflower) intake was associated with decreased menopausal symptoms
and fatigue in white BCS
Coughlin et al., 2015; Nomura et al., 2018; Pereira et al., 2018; Zick et al., 2017
39. Fatigue-Reduction Diet
o Improved fatigue and sleep quality in BCS when compared to control
group during a 3-month intervention
• Researchers hypothesize that a diet high in antioxidants decreases
inflammation and thus, alleviates fatigue
• Maintained baseline calories, but replaced typical foods with fatty fish,
nuts and seeds, whole grains, fruits, and vegetables (particularly green
leafy vegetables/tomatoes)
Zick et al., 2017
40. Dietary Supplements and CRF
o A systematic review aimed to identify dietary supplements beneficial in CRF
• Chlorella extracts and granules reduced fatigue in one study
• Coconut oil was beneficial in one study of patients receiving chemotherapy
• Ginseng may provide a small benefit
• Guarana studies show mixed results and adverse side effects
• CoQ 10 with vitamin E did not reduce CRF
• Acetyl-l-carnitine NOT recommended – risks outweigh the benefits
• Discuss with your oncologist - supplements may interact negatively with
oncologic treatment
Pereira et al., 2018
41. In Summary
o No magic bullet
o CRF is complex and not well-understood
o Exercise shows the biggest reduction in symptoms
o Resistance exercise, coupled with aerobic exercise and/or HIIT, is
recommended
o Increase consumption of omega-3 rich fish, nuts, and seeds, whole
grains, fruits, and vegetables
o Engage in activities that improve your sense of well-being and provide
social support
43. References
Alcântara-Silva, T. R., de Freitas-Junior, R., Freitas, N., de Paula Junior, W., da Silva, D. J., Machado, G., Ribeiro, M., Carneiro, J. P., & Soares,
L. R. (2018). Music Therapy Reduces Radiotherapy-Induced Fatigue in Patients With Breast or Gynecological Cancer: A Randomized Trial.
Integrative cancer therapies, 17(3), 628–635. https://doi.org/10.1177/1534735418757349
Berger, A. M., Gerber, L. H., & Mayer, D. K. (2012). Cancer-related fatigue: implications for breast cancer survivors. Cancer, 118(8 Suppl),
2261–2269. https://doi.org/10.1002/cncr.27475
Bjerkeset, E., Röhrl, K., & Schou-Bredal, I. (2020). Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors:
prevalence and characteristics. Breast cancer research and treatment, 180(1), 63–71. https://doi.org/10.1007/s10549-020-05522-8
Bower, J. E., Wiley, J., Petersen, L., Irwin, M. R., Cole, S. W., & Ganz, P. A. (2018). Fatigue after breast cancer treatment: Biobehavioral
predictors of fatigue trajectories. Health psychology : official journal of the Division of Health Psychology, American Psychological
Association, 37(11), 1025–1034. https://doi.org/10.1037/hea0000652
Coughlin, S. S., Yoo, W., Whitehead, M. S., & Smith, S. A. (2015). Advancing breast cancer survivorship among African-American women.
Breast cancer research and treatment, 153(2), 253–261. https://doi.org/10.1007/s10549-015-3548-3
Dong, B., Xie, C., Jing, X., Lin, L., & Tian, L. (2019). Yoga has a solid effect on cancer-related fatigue in patients with breast cancer: a meta-
analysis. Breast cancer research and treatment, 177(1), 5–16. https://doi.org/10.1007/s10549-019-05278-w
Ehlers, D. K., DuBois, K., & Salerno, E. A. (2020). The effects of exercise on cancer-related fatigue in breast cancer patients during primary
treatment: a meta-analysis and systematic review. Expert review of anticancer therapy, 20(10), 865–877.
https://doi.org/10.1080/14737140.2020.1813028
Fox, R. S., Ancoli-Israel, S., Roesch, S. C., Merz, E. L., Mills, S. D., Wells, K. J., Sadler, G. R., & Malcarne, V. L. (2020). Sleep disturbance and
cancer-related fatigue symptom cluster in breast cancer patients undergoing chemotherapy. Supportive care in cancer : official journal of
the Multinational Association of Supportive Care in Cancer, 28(2), 845–855. https://doi.org/10.1007/s00520-019-04834-w
Gebruers, N., Camberlin, M., Theunissen, F., Tjalma, W., Verbelen, H., Van Soom, T., & van Breda, E. (2019). The effect of training
interventions on physical performance, quality of life, and fatigue in patients receiving breast cancer treatment: a systematic review.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 27(1), 109–122.
https://doi.org/10.1007/s00520-018-4490-9
44. Hagstrom, A. D., Marshall, P. W., Lonsdale, C., Cheema, B. S., Fiatarone Singh, M. A., & Green, S. (2016). Resistance training improves fatigue and
quality of life in previously sedentary breast cancer survivors: a randomised controlled trial. European journal of cancer care, 25(5), 784–794.
https://doi.org/10.1111/ecc.12422
Huang, H. P., Wen, F. H., Yang, T. Y., Lin, Y. C., Tsai, J. C., Shun, S. C., Jane, S. W., & Chen, M. L. (2019). The effect of a 12-week home-based walking
program on reducing fatigue in women with breast cancer undergoing chemotherapy: A randomized controlled study. International journal of
nursing studies, 99, 103376. https://doi.org/10.1016/j.ijnurstu.2019.06.007
Inglis, J. E., Janelsins, M. C., Culakova, E., Mustian, K. M., Lin, P. J., Kleckner, I. R., & Peppone, L. J. (2020). Longitudinal assessment of the impact of
higher body mass index on cancer-related fatigue in patients with breast cancer receiving chemotherapy. Supportive care in cancer : official journal
of the Multinational Association of Supportive Care in Cancer, 28(3), 1411–1418. https://doi.org/10.1007/s00520-019-04953-4
Juvet, L. K., Thune, I., Elvsaas, I., Fors, E. A., Lundgren, S., Bertheussen, G., Leivseth, G., & Oldervoll, L. M. (2017). The effect of exercise on fatigue
and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: A meta-analysis. Breast (Edinburgh,
Scotland), 33, 166–177. https://doi.org/10.1016/j.breast.2017.04.003
Kim, S., Han, J., Lee, M. Y., & Jang, M. K. (2020). The experience of cancer-related fatigue, exercise and exercise adherence among women breast
cancer survivors: Insights from focus group interviews. Journal of clinical nursing, 29(5-6), 758–769. https://doi.org/10.1111/jocn.15114
Kinkead, B., Schettler, P. J., Larson, E. R., Carroll, D., Sharenko, M., Nettles, J., Edwards, S. A., Miller, A. H., Torres, M. A., Dunlop, B. W., Rakofsky, J. J.,
& Rapaport, M. H. (2018). Massage therapy decreases cancer-related fatigue: Results from a randomized early phase trial. Cancer, 124(3), 546–554.
https://doi.org/10.1002/cncr.31064
Mijwel, S., Backman, M., Bolam, K. A., Jervaeus, A., Sundberg, C. J., Margolin, S., Browall, M., Rundqvist, H., & Wengström, Y. (2018). Adding high-
intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the
OptiTrain randomized controlled trial. Breast cancer research and treatment, 168(1), 79–93. https://doi.org/10.1007/s10549-017-4571-3
Nomura, S., Hwang, Y. T., Gomez, S. L., Fung, T. T., Yeh, S. L., Dash, C., Allen, L., Philips, S., Hilakivi-Clarke, L., Zheng, Y. L., & Wang, J. H. (2018). Dietary
intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors.
Breast cancer research and treatment, 168(2), 467–479. https://doi.org/10.1007/s10549-017-4578-9
Pereira, P., Reis, A. D., Diniz, R. R., Lima, F. A., Leite, R. D., da Silva, M., Guerra, R., de Moraes Vieira, É. B., & Garcia, J. (2018). Dietary supplements
and fatigue in patients with breast cancer: a systematic review. Breast cancer research and treatment, 171(3), 515–526.
https://doi.org/10.1007/s10549-018-4857-0
45. Person, H., Guillemin, F., Conroy, T., Velten, M., & Rotonda, C. (2020). Factors of the evolution of fatigue dimensions in patients with breast
cancer during the 2 years after surgery. International journal of cancer, 146(7), 1827–1835. https://doi.org/10.1002/ijc.32527
Puigpinós-Riera, R., Serral, G., Sala, M., Bargalló, X., Quintana, M. J., Espinosa, M., Manzanera, R., Doménech, M., Macià, F., Grau, J., &
Vidal, E. (2020). Cancer-related fatigue and its determinants in a cohort of women with breast cancer: the DAMA Cohort. Supportive care
in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 28(11), 5213–5221.
https://doi.org/10.1007/s00520-020-05337-9
Schmidt, M. E., Wiskemann, J., Armbrust, P., Schneeweiss, A., Ulrich, C. M., & Steindorf, K. (2015). Effects of resistance exercise on fatigue
and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial. International journal of
cancer, 137(2), 471–480. https://doi.org/10.1002/ijc.29383
Schmidt, M. E., Wiskemann, J., Schneeweiss, A., Potthoff, K., Ulrich, C. M., & Steindorf, K. (2018). Determinants of physical, affective, and
cognitive fatigue during breast cancer therapy and 12 months follow-up. International journal of cancer, 142(6), 1148–1157.
https://doi.org/10.1002/ijc.31138
Sørensen, H. L., Schjølberg, T. K., Småstuen, M. C., & Utne, I. (2020). Social support in early-stage breast cancer patients with fatigue. BMC
women's health, 20(1), 243. https://doi.org/10.1186/s12905-020-01106-2
Tang, Y., Fu, F., Gao, H., Shen, L., Chi, I., & Bai, Z. (2019). Art therapy for anxiety, depression, and fatigue in females with breast cancer: A
systematic review. Journal of psychosocial oncology, 37(1), 79–95. https://doi.org/10.1080/07347332.2018.1506855
Williams, A. M., Khan, C. P., Heckler, C. E., Barton, D. L., Ontko, M., Geer, J., Kleckner, A. S., Dakhil, S., Mitchell, J., Mustian, K. M., Peppone,
L. J., Kipnis, V., Kamen, C. S., O'Mara, A. M., & Janelsins, M. C. (2021). Fatigue, anxiety, and quality of life in breast cancer patients
compared to non-cancer controls: a nationwide longitudinal analysis. Breast cancer research and treatment, 187(1), 275–285.
https://doi.org/10.1007/s10549-020-06067-6
Zick, S. M., Colacino, J., Cornellier, M., Khabir, T., Surnow, K., & Djuric, Z. (2017). Fatigue reduction diet in breast cancer survivors: a pilot
randomized clinical trial. Breast cancer research and treatment, 161(2), 299–310. https://doi.org/10.1007/s10549-016-4070-y